Cutler Group LP Agios Pharmaceuticals, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutler Group LP holds 7,130 shares of AGIO stock, worth $291,403. This represents 0.07% of its overall portfolio holdings.

Number of Shares

7,130

Previous 7,000 1.86%

Holding current value

$291,403

Previous $155,000 34.19%

% of portfolio

0.07%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$21.32 - $34.81 $2,771 - $4,525	130 Added 1.86%	7,130 $208,000
Q4 2023 Jan 18, 2024	BUY	$19.97 - $24.53 $51,922 - $63,778	2,600 Added 59.09%	7,000 $155,000
Q1 2023 May 01, 2023	SELL	$21.74 - $30.93 $23,914 - $34,023	-1,100 Reduced 20.0%	4,400 $101,000
Q4 2022 Feb 07, 2023	BUY	$24.81 - $31.52 $49,620 - $63,040	2,000 Added 57.14%	5,500 $154,000
Q3 2022 Oct 25, 2022	SELL	$19.51 - $34.14 $13,657 - $23,898	-700 Reduced 16.67%	3,500 $98,000
Q2 2022 Aug 04, 2022	SELL	$17.06 - $31.42 $2,934 - $5,404	-172 Reduced 3.93%	4,200 $93,000
Q1 2022 Apr 14, 2022	SELL	$26.68 - $34.81 $16,008 - $20,886	-600 Reduced 12.07%	4,372 $127,000
Q2 2021 Jul 19, 2021	SELL	$52.06 - $61.27 $89,959 - $105,874	-1,728 Reduced 25.79%	4,972 $274,000
Q4 2020 Jan 21, 2021	SELL	$33.21 - $46.54 $3,321 - $4,654	-100 Reduced 1.47%	6,700 $290,000
Q2 2020 Jul 22, 2020	BUY	$34.45 - $53.48 $86,125 - $133,700	2,500 Added 58.14%	6,800 $363,000
Q1 2020 May 07, 2020	SELL	$31.52 - $53.81 $88,256 - $150,668	-2,800 Reduced 39.44%	4,300 $152,000
Q4 2019 Feb 06, 2020	SELL	$30.08 - $50.59 $11,159 - $18,768	-371 Reduced 4.97%	7,100 $339,000
Q2 2019 Aug 09, 2019	BUY	$46.17 - $68.1 $71,378 - $105,282	1,546 Added 26.09%	7,471 $372,000
Q1 2019 May 10, 2019	SELL	$45.92 - $67.67 $156,128 - $230,078	-3,400 Reduced 36.46%	5,925 $399,000
Q4 2018 Feb 05, 2019	BUY	$42.73 - $76.53 $180,534 - $323,339	4,225 Added 82.84%	9,325 $429,000
Q3 2018 Nov 07, 2018	SELL	$71.67 - $91.95 $193,509 - $248,265	-2,700 Reduced 34.62%	5,100 $393,000
Q2 2018 Aug 10, 2018	BUY	$73.22 - $99.55 $511,954 - $696,053	6,992 Added 865.35%	7,800 $656,000
Q1 2018 May 11, 2018	SELL	$59.83 - $86.53 $11,966 - $17,306	-200 Reduced 19.84%	808 $66,000
Q4 2017 Jan 17, 2018	SELL	$52.12 - $72.33 $317,098 - $440,055	-6,084 Reduced 85.79%	1,008 $57,000
Q3 2017 Oct 17, 2017	BUY	$54.89 - $67.12 $389,279 - $476,015	7,092	7,092 $473,000

Others Institutions Holding AGIO

# of Institutions

236

Shares Held

61.8M

Call Options Held

297K

Put Options Held

235K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account